2541 Background: The epidermal growth factor receptor (EGFR) is a cell surface tyrosine kinase receptor associated with cell proliferation and differentiation. EGFR expression and activating mutations are associated with aggressive neoplastic disease, chemotherapy resistance, and increased metastatic potential. Published data and EGFR immunohistochemistry (IHC) performed on tissue microarrays indicate that 15-40% of pediatric solid tumors (ST) express EGFR. The unique EGFR monoclonal antibody (mAb) 806 selectively binds to an epitope that is conformationally hidden when EGFR is tethered but revealed when tethering is perturbed as occurs with EGFR overexpression, truncation, or through extra-cellular domain missense mutations. Methods: Children and young adults (CYA) with EGFR-expressing recurrent/refractory (R/R) ST were enrolled on a Phase 1 trial to examine the safety and feasibility of administering autologous chimeric antigen receptor (CAR) T cells derived from autologous T cells genetically modified to express a second generation EGFR806-specific scFV-IgG4hinge-CD28tm/cyto-4-1-BB-zeta and EGFRt tracking/suicide contract. All subjects received lymphodepleting chemotherapy with fludarabine and cyclophosphamide prior to the administration of cryopreserved CAR T cells a the prescribed dose level. The biologically effective dose (BED) or maximum tolerated dose was determined based upon observed toxicity through day 28 from initial CAR-T infusion and using a 3+3 statistical design. Results: Eleven subjects (n=10 evaluable, age range 9-25, median 18) were enrolled and received either dose level (DL) 1 (0.5 x 106 CAR-T/kg, n=4) or DL2 (1 x 106 CAR-T cells/kg, n=7). CAR T were manufactured successfully in all subjects. Most common toxicities were fatigue, tumor-related pain and cytokine release syndrome (n=2, maximum CTCAE grade 1). Dose limiting toxicity of CTCAE grade 4 transaminase level and hyperbilirubinemia occurred at DL2 (n=1). Maximum circulating CAR-T expansion was 29.66 cells/uL (range 0.05-29.66 cells/uL) with median persistence of 28 days (range 0-90). Two subjects on DL1 and one subject on DL2 demonstrated mixed response on day 28 and tolerated additional CAR T infusion without dose limiting toxicity. Conclusions: EGFR806 directed CAR-T cells have an acceptable toxicity profile in CYA with R/RST and demonstrate anti-tumor activity in some patients. Additional analyses are ongoing to identify biomarkers of response and toxicity. Clinical trial information: NCT03618381.
Adrenocortical carcinoma (ACC) is a rare but clinically aggressive endocrine malignancy. Circular RNAs (circRNAs) were found to play key roles in tumorigenesis. In the current study, we aimed to investigate the functions and mechanisms of a novel circRNA, circ‐CCAC1, in ACC cells. circ‐CCAC1 expression levels in ACC tissue specimens and cell lines were evaluated by RT‐qPCR. Kaplan‐Meier analysis was applied to explore the relationship between circ‐CCAC1 and patients’ prognosis. Cell counting kit‐8 (CCK‐8), colony formation, acridine orange/ethidium bromide (AO/EB) double fluorescence staining, and Transwell assays were performed to evaluate the functions of circ‐CCAC1 in ACC cells. Bioinformatics analysis and a dual‐luciferase reporter assay were utilized to explore the mechanisms of circ‐CCAC1. As a result, circ‐CCAC1 was overexpressed in ACC tissue samples and cell lines and correlated with poor prognosis. Gain‐ and loss‐of‐function tests demonstrated that circ‐CCAC1 acted as an oncogene in ACC. What is more, circ‐CCAC1 enhanced C22orf46 expression by sponging miR‐514a‐5p in ACC cells. A rescue assay illustrated that circ‐CCAC1 facilitated ACC progression through miR‐514a‐5p/C22orf46 signaling. To sum up, we identified a novel circRNA, circ‐CCAC1, which may be used as a potential therapeutic target for ACC.
A new algorithm for clipping a line segment in two dimension against a rectangular window is presented in this paper. The algorithm are different to the others of line clipping algorithms. This algorithm use the affine transformations (Shearing transformations) to transform the line segment and the window, which make the process of clipping the line segment very simple and avoid solving the equations set to get the points of intersections which are made by the line segment and the window. Comparing to some classical algorithms, the algorithm of this paper are faster for the speeds of clipping the line segment and more efficiency for the calculations.
Providing reliable and efficient multicast services is one of the most important issues of the emerging 5G network. As the number of users grows rapidly, non-feedback multicast schemes are more suitable for bandwidth efficiency. However, conventional non-feedback multicast solutions, like the well-known Random Linear Network Coding (RLNC) and Systematic Network Coding (SNC), are suffering from complicated packet decoding and redundant packet reception at the unsaturated users. In this paper, we propose a reliable Hybrid Systematic Network Coding (HSNC) scheme to fully solve these problems. HSNC utilizes both deterministic and randomly generated coding vectors over the same finite field. By subtracting coding vectors with zero elements from a Reed- Solomon coding matrix, the goal to maximize the number of linear independent rows of a coding matrix can be easily realized. Close-form expressions of bit overhead ratio, decoding probability and computational cost are derived out. Numerical results show that HSNC, with or without a sliding window, outperforms RLNC and SNC in terms of the decoding probability. Moreover, HSNC has lower bit overhead and computational cost.
13 June 2022 in EURASIP Journal on Wireless Communications and Networking
Mobile edge computing (MEC) is considered as a key enabler for the industrial internet of things (IIoT) to cope with the ever-increasing communication and computing demands of nodes. In consideration of the limited resource of the IIoT nodes, it is necessary to design cost-effective multi-hop data transmission schemes for mobile edge IIoTs. However, most of the traditional schemes have to spend enormous cost to meet the reliability requirement, which cannot support timely information processing of MEC-based IIoT. In this article, the probabilistic cooperative coded forwarding (PCCF) scheme for multi-hop data transmission in mobile edge IIoTs is proposed to address the above problem. First, the data packets are encoded at a source IIoT node using the systematic sparse network coding (SSNC) mechanism, then the source broadcasts the coded packets to its one-hop neighbors. To minimize the required number of redundant coded packets, the sparsity of coded packets is optimized. Second, the nodes which received the packets will become volunteer relay nodes and forward the coded packets using the cooperative coded forwarding (CCF) mechanism. The volunteer relays first forward the received coded packets with a forwarding probability, and then re-encode a pair of received coded packets and broadcast the re-encoded packet with a re-encoding probability. To guarantee the broadcast performance while minimizing the transmission number at relay nodes, the feasible forwarding and re-encoding probability are provided. Third, the receiver nodes will try to decode the received coded and re-encoded packets and recover data packets without sending acknowledgments. Finally, through a series of experiments, we verify the accuracy of analytical approximations and also find out the optimal sparsity of coded packets and the existence of minimum transmission numbers. These provide insights for further optimization of multi-hop data transmission in mobile edge IIoTs.